Integration of Continuous Renal Replacement Therapy in a Meropenem Population Pharmacokinetics Model in Critically Ill Children

Схожие документы

• Reply to Béranger et al., “Integration of Continuous Renal Replacement Therapy in a Meropenem Population Pharmacokinetics Model in Critically Ill Children”
  по: Saito, Jumpei, et al.
  Опубликовано: (2021)
• Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
  по: Solé Violan, J, et al.
  Опубликовано: (2014)
• Population pharmacokinetics of standard-dose meropenem in critically ill patients on continuous renal replacement therapy: a prospective observational trial
  по: Onichimowski, Dariusz, et al.
  Опубликовано: (2020)
• Meropenem Population Pharmacokinetics in Critically Ill Patients with Septic Shock and Continuous Renal Replacement Therapy: Influence of Residual Diuresis on Dose Requirements
  по: Ulldemolins, Marta, et al.
  Опубликовано: (2015)
• Influence of Renal Replacement Modalities on Amikacin Population Pharmacokinetics in Critically Ill Patients on Continuous Renal Replacement Therapy
  по: Roger, Claire, et al.
  Опубликовано: (2016)